Status:
RECRUITING
Survivorship After HNC: A Randomized Controlled Trial Evaluating Patient Care and Adherence to Follow-up
Lead Sponsor:
Western University, Canada
Conditions:
Head and Neck Cancer
Survivorship
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Treatment summary and survivorship care plans (TSSPs) are poorly studied in Head and Neck Cancer (HNC) patients, and given the high frequency of unmet needs, this patient population has potentially th...
Detailed Description
This study is a longitudinal randomized controlled trial. Patients will be randomly assigned to either usual treatment or the intervention (MI counselling session). Data will be collected at four time...
Eligibility Criteria
Inclusion
- Patient Participants
- Age 18 years or older
- Willing to provide informed consent
- Diagnosis of stage I-IVA head and neck mucosal cancer (larynx, hypopharynx, oral cavity, oropharynx, nasopharynx)
- Last definitive treatment (surgery, chemotherapy, radiotherapy) between 3 and 6 months prior to enrollment
- English speaking, reading and writing
Exclusion
- Second concurrent non-cutaneous malignancy
- Metastatic disease
- Clinically apparent cognitive impairment
- Suspected residual disease after treatment completion
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT06127784
Start Date
May 1 2025
End Date
July 1 2027
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Victoria Hospital, London Health Sciences Centre
London, Ontario, Canada, N6A 5W9